Anesthesiology and Pulmonary Medicine
Nano Mask Enters Into Four-Year Distribution Agreement With Saudi Medical Products Distributor
August 25, 2011 8:37 am | by Bio-Medicine.Org | News | CommentsFISHKILL, N.Y., Aug. 25, 2011 /- Nano Mask, Inc. (NMI) (Pink Sheets: NANM ), a healthcare product development and distribution company focused on emergency and critical care as well as infection control markets, has announced that it has entered into a distribution agreement with a Saudi...
Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011(2)
August 25, 2011 5:38 am | by Bio-Medicine.Org | News | CommentsSAINT PAUL, Minnesota, Aug. 25, 2011 /- Angeion Corporation (NASDAQ: ANGN ) today scheduled a conference call to discuss its financial results for the third quarter of fiscal year 2011, ended July 31, 2011. The call will be at 4:30 p.m. ET on Thursday, September 1, 2011. The Company will...
2nd Day of Testimony: Mainor Eglet Attorney Continues Questioning Teva Pharmaceuticals Vice President
August 24, 2011 9:42 am | by Bio-Medicine.Org | News | CommentsLAS VEGAS, Aug. 24, 2011 /- "Production of Propofol was stopped after the Chanin trial in 2010 due to public outcry," said Robert Eglet attorney for the plaintiffs. In a stunning turn in the Anne Arnold Hepatitis C trial in Clark County, Attorney Robert Eglet told the jury that production...
Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
August 23, 2011 7:42 am | by Bio-Medicine.Org | News | CommentsYORK, Pa., Aug. 23, 2011 /- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ; ASX: UNS) today announced the development and patenting of the Unifill® EZMix multiple-chamber ready-to-fill (prefilled) syringes. Unifill EZMix syringes have been developed in direct...
Mainor Eglet Attorney, Robert Eglet, Calls Teva Pharmaceuticals Vice President Craig Lea to the Stand in Hepatitis C Trial
August 22, 2011 11:40 pm | by Bio-Medicine.Org | News | CommentsLAS VEGAS, Aug. 22, 2011 /- Craig Lea, Vice President of Teva Pharmaceuticals, was the first witness called in the second hepatitis C trial following the largest notification by the Clark County Health Department to 50,000 residents they may have been affected. Lead Trial Attorney for the...
HeartLightâ„¢ Endoscopic Ablation System Now Available in the UK
August 22, 2011 3:47 am | by Bio-Medicine.Org | News | CommentsMARLBOROUGH, Mass., Aug. 22, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that the HeartLight EAS is now available in the United Kingdom. The first AF patients were treated at The...
FDA Approves Adcetris to Treat Two Types of Lymphoma
August 19, 2011 5:43 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL). (Logo:...
Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services
August 19, 2011 5:43 pm | by Bio-Medicine.Org | News | CommentsWASHINGTON, Aug. 19, 2011 /PRNewswire-USNewswire/ -- As Medicare expands a controversial "competitive" bidding program for home medical equipment and services, economists, consumer groups, and members of Congress have gone on record to oppose that program citing reduced patient access to...
Nyx Devices' sleep-monitoring shirt attracts $500K
August 19, 2011 7:41 am | by Mass High Tech: The Journal of New England Technology | News | CommentsMIT researchers have developed sleep-monitoring technology in the form of an electronic T-shirt, and now their company, Nyx Devices Inc., is reaping the benefits. The startup announced in a regulatory filing Thursday that it has secured a $500,000 financing via equity and securities.
Syndax scores EU patent for potential cancer therapeutic
August 17, 2011 10:40 am | by Mass High Tech: The Journal of New England Technology | News | CommentsSyndax Pharmaceuticals Inc. has been granted a patent from the European Patent Office for an oral HDAC inhibitor, called entinostat, to treat metastatic breast cancer and advanced non-small cell lung cancer.
Seattle Children's Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year
August 16, 2011 9:41 am | by Bio-Medicine.Org | News | CommentsSEATTLE, Aug. 16, 2011 /PRNewswire-USNewswire/ -- Seattle Children's Research Institute today announced the receipt of a two-year, $2.3 million grant from the Bill & Melinda Gates Foundation to complete prototype development of its new respiratory support device, called Seattle...
Pulmatrix pulls in $14M in Series B round
August 15, 2011 5:42 am | by Mass High Tech: The Journal of New England Technology | News | CommentsPulmatrix Inc., a Lexington biotechnology company focused on respiratory diseases, has taken in $14 million in a Series B1 funding round, from all previous including Polaris Venture Partners, 5AM Ventures, Arch Venture Partners, and Novartis Venture Fund.
Mylan Launches Generic Version of Uroxatral® Tablets
August 12, 2011 4:40 am | by Bio-Medicine.Org | News | CommentsPITTSBURGH, Aug. 12, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg. This product is the generic version of Uroxatral®, a treatment for signs and symptoms of benign...
China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results
August 11, 2011 3:42 am | by Bio-Medicine.Org | News | CommentsHAIKOU CITY, China, Aug. 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI ) ("China Pharma" or the "Company"), a specialty pharmaceuticals company in China, today announced financial results for the quarter ended June 30, 2011. Second Quarter 2011...
Boston Scientific Launches Neuromodulation Learning Institute To Enhance Clinical Education For Spinal Cord Stimulation(2)
August 10, 2011 4:39 am | by Boston Scientific | News | CommentsCompany also introduces industry's first iPhone®/iPad® app for healthcare professionals using SCS
Study of Tricuspid Valve Mechanics Uncovers Causes for Leakage
August 9, 2011 8:40 am | by Georgia Tech Institute of Technology | News | CommentsMillions experience leakage from their heart's tricuspid valve, but what causes it is not well understood. A new study found that either dilating the valve opening or displacing the papillary muscles that control its operation can cause the valve to leak.
Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems
August 9, 2011 5:38 am | by Bio-Medicine.Org | News | CommentsVANCOUVER, British Columbia, Aug. 9, 2011 /- Medical physicists researching RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR ) have reported that, compared with conventional approaches to radiotherapy, RapidArc treatment plans for lung, abdominal and spinal...
Global Health Ventures August 4th Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
August 8, 2011 11:41 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Aug. 8, 2011 /- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery announced today that their August 4th RetailInvestorConferences.com presentation by Dr. Hassan Salari PhD, Chairman and CEO, is available for...
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011
August 8, 2011 5:35 am | by Bio-Medicine.Org | News | CommentsMONMOUTH JUNCTION, N.J., Aug. 8, 2011 /- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011. Key Recent Highlights: Announced positive results through six cycles of data from the open-label...
South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeamâ„¢ Radiotherapy System from Varian Medical Systems
August 5, 2011 8:43 am | by Bio-Medicine.Org | News | CommentsBOCA RATON and JUPITER, Fla., Aug. 5, 2011 /- In a promising development for cancer patients in The Palm Beach area, South Florida Radiation Oncology announced today that it has acquired the TrueBeam system, an innovative system that enables a radically different approach to treating...
Mold exposure during infancy increases asthma risk
August 4, 2011 7:33 am | by EurekAlert | News | Comments(University of Cincinnati Academic Health Center) Infants who live in "moldy" homes are three times more likely to develop asthma by age 7 -- an age that children can be accurately diagnosed with the condition.
Dehaier Medical to Report Second Quarter 2011 Financial Results on August 15
August 4, 2011 4:37 am | by Bio-Medicine.Org | News | CommentsBEIJING, Aug. 4, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...
PRA Expert's Pulmonary Function Textbook Reissued
August 2, 2011 6:40 am | by Bio-Medicine.Org | News | CommentsRALEIGH, N.C., Aug. 2, 2011 /- PRA, a leading Clinical Research Organization, announces that the third edition of respiratory care expert Jack Wanger's book, Pulmonary Function Testing: A Practical Approach , has recently been published by Jones & Bartlett Learning in Sudbury, MA. Mr....
MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
August 2, 2011 4:40 am | by Bio-Medicine.Org | News | CommentsMOUNTAIN VIEW, Calif., Aug. 2, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and...
Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
August 1, 2011 4:42 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Aug. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts...
